Rapid Enumeration of Bioburden in a Model Sample Matrix for Influenza Vaccine Using the Growth Direct™ System

This informative study demonstrates that Growth Direct analyzes microbial contaminants in egg white, a model matrix for allantoic fluid, more rapidly than traditional culture methods—up to 50% faster.

The time savings combined with lower labor costs and improved compliance result in:

• Significantly lower manufacturing costs by reducing hold times between manufacturing steps and speeding release of product 
• Free personnel to perform other, higher-value tasks
• Reduce product scrap by shortening response times to microbial contamination 
• Improve overall QC, QA, and manufacturing efficiency 

These benefits can result in a payback on the initial investment of the Growth Direct system within two years or less!

Fill out the form to get instant access to this study.